Insider Trading History of Thompson Peter A.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Thompson Peter A. since year 2005. The trader's CIK number is 1357522. At the time of the last reporting, Thompson Peter A. was the Officer of Corvus Pharmaceuticals, Inc. . (stock ticker symbol CRVS). See this page for all insider trading activities at Corvus Pharmaceuticals, Inc. .

Note that in the past Thompson Peter A. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Thompson Peter A. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-06-28 CRVS Corvus Pharmaceuticals, Inc. Buy 565,178 3.72 2,102,462
2019-07-01 CRVS Corvus Pharmaceuticals, Inc. Buy 59,243 3.91 231,640
2019-06-27 CRVS Corvus Pharmaceuticals, Inc. Buy 32,923 3.34 109,962
2019-06-24 PRVL Prevail Therapeutics Inc. Buy 882,352 17.00 14,999,984
2019-01-18 ALPN Alpine Immune Sciences, Inc. Buy 372,439 5.37 1,999,997
2018-12-11 THOR Synthorx, Inc. Buy 1,363,636 11.00 14,999,996
2018-06-04 ADAP Adaptimmune Therapeutics Plc Sale 17,100 13.57 232,047
2018-06-06 ADAP Adaptimmune Therapeutics Plc Sale 1,600 13.49 21,584
2018-05-30 ADAP Adaptimmune Therapeutics Plc Sale 121,000 13.52 1,635,920
2018-06-01 ADAP Adaptimmune Therapeutics Plc Sale 50,000 13.49 674,500
2018-05-14 ADAP Adaptimmune Therapeutics Plc Sale 10,300 13.50 139,050
2018-03-27 ADAP Adaptimmune Therapeutics Plc Sale 1,016,084 11.50 11,684,966
2018-03-29 ADAP Adaptimmune Therapeutics Plc Sale 31,983 11.53 368,763
2018-03-12 CRVS Corvus Pharmaceuticals, Inc. Buy 588,235 8.50 4,999,997
2017-03-27 ADAP Adaptimmune Therapeutics Plc Buy 1,190,476 4.20 4,999,999
2016-06-23 CRVS Corvus Pharmaceuticals, Inc. Buy 100 12.92 1,292
2016-06-24 CRVS Corvus Pharmaceuticals, Inc. Buy 900 12.99 11,691
2016-06-17 CRVS Corvus Pharmaceuticals, Inc. Buy 12,300 12.48 153,504
2016-06-21 CRVS Corvus Pharmaceuticals, Inc. Buy 26,083 12.87 335,688
2016-06-16 RBM Response Biomedical Corp Buy 892,858 .56 500,000
2016-06-16 RBM Response Biomedical Corp Buy 892,858 .56 500,000
2016-06-14 CRVS Corvus Pharmaceuticals, Inc. Buy 10,000 12.71 127,100
2016-06-15 CRVS Corvus Pharmaceuticals, Inc. Buy 5,000 11.94 59,700
2016-06-16 CRVS Corvus Pharmaceuticals, Inc. Buy 5,000 12.04 60,199
2016-06-09 CRVS Corvus Pharmaceuticals, Inc. Buy 30,000 12.95 388,500
2016-06-10 CRVS Corvus Pharmaceuticals, Inc. Buy 20,000 12.98 259,600
2016-05-20 ADAP Adaptimmune Therapeutics Plc Buy 2,400 10.04 24,095
2016-05-24 ADAP Adaptimmune Therapeutics Plc Buy 518,400 10.48 5,432,832
2016-05-23 ADAP Adaptimmune Therapeutics Plc Buy 1,191,600 10.40 12,392,640
2016-05-20 CRVS Corvus Pharmaceuticals, Inc. Buy 4,716 13.09 61,732
2016-05-18 CRVS Corvus Pharmaceuticals, Inc. Buy 4,200 11.55 48,510
2016-05-19 CRVS Corvus Pharmaceuticals, Inc. Buy 2,600 12.43 32,318
2016-03-29 CRVS Corvus Pharmaceuticals, Inc. Buy 550,000 15.00 8,250,000
2015-07-21 DNAI Sierra Oncology, Inc. Buy 175,000 17.00 2,975,000
2009-05-22 TRBN Trubion Pharmaceuticals, Inc Option Ex 126,387 .31 39,685
2007-11-19 TRBN Trubion Pharmaceuticals, Inc Buy 5,000 9.99 49,935
2006-10-18 TRBN Trubion Pharmaceuticals, Inc Buy 1,000 13.00 13,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Thompson Peter A. (Officer of Corvus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.